The India microbiology testing market size reached USD 183.93 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 475.36 Million by 2033, exhibiting a growth rate (CAGR) of 10.26% during 2025-2033. The India microbiology testing market share is expanding, driven by the increasing reliance on advanced tests to detect bacterial, viral, and fungal infections accurately, along with the rising development of new medicines that need microbiology testing to study microbial behavior.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 183.93 Million |
Market Forecast in 2033 | USD 475.36 Million |
Market Growth Rate 2025-2033 | 10.26% |
Growing incidence of infectious diseases
The increasing incidence of infectious diseases is offering a favorable India microbiology testing market outlook. With outbreaks of diseases like tuberculosis, dengue, and antimicrobial-resistant infections becoming more common, healthcare providers need efficient diagnostic solutions to manage and control the spread of illnesses. According to industry reports, the Municipal Corporation of Delhi (MCD) confirmed that the total number of dengue infections in the city surpassed 4,000 in 2024, with 467 new cases recorded in the weekly cycle that concluded on November 2. Microbiology testing aids in identifying pathogens, guiding treatment decisions, and preventing complications, making it a crucial part of the healthcare system. The growing concerns about hospital-acquired infections is also encouraging more hospitals to adopt routine microbiology testing to ensure patient safety. Additionally, the rise in lifestyle diseases, such as diabetes, weakens immunity, making individuals more vulnerable to infections, creating the need for accurate testing. The expansion of diagnostic chains and healthcare facilities, especially in rural areas, is making microbiology testing more accessible. Government initiatives to strengthen disease surveillance and control, along with efforts to improve public healthcare infrastructure, are also playing a key role in catalyzing the demand for these tests. With ongoing innovations in diagnostic technology, microbiology testing is becoming faster and more reliable, assuring better patient outcomes and supporting the high requirement for efficient disease management across the country.
Rising applications in biotechnology industry
Increasing applications in the biotechnology industry are fueling the India microbiology testing market growth. Biotech companies rely on these tests for research, drug development, and quality control. With increasing investments in pharmaceuticals, vaccines, and bio-based products, microbiology testing is being employed to ensure the safety and efficacy of biotechnological innovations. Companies developing new medicines and therapies need microbiology testing to detect contamination and maintain regulatory compliance. The rise of biopharmaceuticals, including monoclonal antibodies and gene therapies, is further creating the need for precise microbial analysis. In agricultural biotechnology, microbiology testing assists in studying soil microbes, manufacturing biofertilizers, and improving crop protection methods. Additionally, advancements in synthetic biology and genetic engineering require continuous microbiological monitoring to maintain sterility and ensure successful outcomes. Government initiatives promoting biotechnology research and startups are also driving the demand for microbiology testing services. As the biotechnology industry thrives, modern testing techniques, such as automation, molecular diagnostics, and next-generation sequencing, are making microbiology testing more efficient, supporting its increasing utilization across research labs and pharmaceutical firms in India. As per the IMARC Group, the India biotechnology market is set to attain USD 110.3 Billion by 2033, showing a growth rate (CAGR) of 13.78% during 2025-2033.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional level for 2025-2033. Our report has categorized the market based on test type, product, indication, application, and end-user.
Test Type Insights:
The report has provided a detailed breakup and analysis of the market based on the test type. This includes bacterial, viral, and fungal.
Product Insights:
A detailed breakup and analysis of the market based on the product have also been provided in the report. This includes instruments and reagents.
Indication Insights:
The report has provided a detailed breakup and analysis of the market based on the indication. This includes respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infection, periodontal diseases, and others.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes pharmaceutical, food testing, clinical, energy, chemical and material manufacturing, and environmental.
End-User Insights:
The report has provided a detailed breakup and analysis of the market based on the end-user. This includes hospitals and diagnostic centers, custom lab service providers, and academic and research institutes.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Test Types Covered | Bacterial, Viral, Fungal |
Products Covered | Instruments, Reagents |
Indications Covered | Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases, Others |
Applications Covered | Pharmaceutical, Food Testing, Clinical, Energy, Chemical and Material Manufacturing, Environmental |
End-Users Covered | Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic and Research Institutes |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |